Adverum Biotechnologies, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$1.40 | -$1.40 | -$1.40 |
| Q2 2024 | 3 | -$1.47 | -$1.47 | -$1.47 |
| Q3 2024 | 3 | -$1.31 | -$1.31 | -$1.31 |
| Q4 2024 | 5 | -$1.48 | -$1.09 | -$1.36 |
| Q1 2025 | 3 | -$1.52 | -$1.17 | -$1.35 |
| Q2 2025 | 2 | -$1.41 | -$1.41 | -$1.41 |
| Q3 2025 | 2 | -$1.32 | -$1.32 | -$1.32 |
| Q4 2025 | 2 | -$1.23 | -$1.23 | -$1.23 |
Adverum Biotechnologies, Inc. Earnings Date And Information
Adverum Biotechnologies, Inc. last posted its earnings results on Monday, November 4th, 2024. The company reported $-1.3 earnings per share for the quarter, missing analysts' consensus estimates of $-1.2 by $0.1. The company had revenue of 1.00 M for the quarter and had revenue of 3.60 M for the year. Adverum Biotechnologies, Inc. has generated $-12 earnings per share over the last year ($-11.62 diluted earnings per share) and currently has a price-to-earnings ratio of -1.34. Adverum Biotechnologies, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based on prior year's report dates.
Adverum Biotechnologies, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/04/2024 | Q3 2024 | -$1.20 | -$1.30 | -0.1 | $125,000 | $1.00 M |
| 08/12/2024 | Q2 2024 | -$1.27 | -$0.89 | 0.38 | $106,000 | $0 |
| 05/09/2024 | Q1 2024 | -$1.28 | -$1.50 | -0.22 | $0 | |
| 03/18/2024 | Q4 2023 | -$2.80 | -$2.34 | 0.46 | $-3,600,000 | |
| 11/09/2023 | Q3 2023 | -$3.00 | -$3.26 | -0.26 | $0 | |
| 08/10/2023 | Q2 2023 | -$3.20 | -$3.13 | 0.07 | $0 | |
| 05/11/2023 | Q1 2023 | -$3.00 | -$2.90 | 0.1 | $3.60 M | |
| 03/30/2023 | Q4 2022 | -$3.28 | $0 | |||
| 11/10/2022 | Q3 2022 | -$3.20 | -$0.40 | 2.8 | $0 | |
| 08/11/2022 | Q2 2022 | -$3.80 | -$0.44 | 3.36 | $0 | |
| 05/12/2022 | Q1 2022 | -$3.40 | -$0.38 | 3.02 | $0 | |
| 03/29/2022 | Q4 2021 | -$4.20 | -$0.35 | 3.85 | $-7,500,000 | |
| 11/04/2021 | Q3 2021 | -$4.20 | -$0.39 | 3.81 | $0 | |
| 08/05/2021 | Q2 2021 | -$3.70 | -$0.45 | 3.25 | $0 | |
| 05/06/2021 | Q1 2021 | -$3.80 | -$0.29 | 3.51 | $7.50 M | |
| 03/01/2021 | Q4 2020 | -$3.20 | -$0.39 | 2.81 | $0 | |
| 11/05/2020 | Q3 2020 | -$3.50 | -$0.31 | 3.19 | $76,667 | $0 |
| 08/10/2020 | Q2 2020 | -$3.00 | -$0.36 | 2.64 | $76,667 | $0 |
| 05/28/2020 | Q1 2020 | -$2.70 | -$0.31 | 2.39 | $0 | |
| 03/12/2020 | Q4 2019 | -$3.10 | -$0.26 | 2.84 | $-250,000 |
Adverum Biotechnologies, Inc. Earnings: Frequently Asked Questions
-
When is Adverum Biotechnologies, Inc.'s earnings date?
Adverum Biotechnologies, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based off last year's report dates.
-
How can I listen to Adverum Biotechnologies, Inc.'s earnings conference call?
The conference call for Adverum Biotechnologies, Inc.'s latest earnings report can be listened to online.
-
How can I read Adverum Biotechnologies, Inc.'s conference call transcript?
The conference call transcript for Adverum Biotechnologies, Inc.'s latest earnings report can be read online.
-
How much revenue does Adverum Biotechnologies, Inc. generate each year?
Adverum Biotechnologies, Inc. (:ADVM) has a recorded annual revenue of $3.60 M.
-
How much profit does Adverum Biotechnologies, Inc. generate each year?
Adverum Biotechnologies, Inc. (:ADVM) has a recorded net income of $3.60 M. Adverum Biotechnologies, Inc. has generated $-11.62 earnings per share over the last four quarters.
-
What is Adverum Biotechnologies, Inc.'s price-to-earnings ratio?
Adverum Biotechnologies, Inc. (:ADVM) has a price-to-earnings ratio of -1.34 and price/earnings-to-growth ratio is -0.05.
